Navigation Links
Wyeth Embroiled in a Lawsuit over its Hormone Replacement Therapy

Monday saw the conclusion of the first of a wave of prescription drug trials with the hearing of the closing arguments as Wyeth defended// its hormone replacement therapy Prempro against claims of increased risk of heart disease, stroke and cancer.

Zoe Littlepage, an attorney for plaintiff Linda Reeves, told the jury at the federal court in Little Rock said, "Wyeth was negligent in not testing the drug and not knowing the truth about their drug."

However Wyeth's lawyer Jane Bockus told the panel of nine women and three men that the company had been warning doctors as early as 1991 of a reported increase in malignancies among patients taking its hormone replacement therapy and that the therapy should not be prescribed for over a year without a follow-up exam.

On Reeves testimony it was revealed that she took Prempro for more than eight years.

Bockus said, "Clearly the label contained adequate information," to allow doctors to decide on patient treatment.

This is the first trial of 5,000 lawsuits filed against Wyeth for Prempro.

Reeves, 67, and her lawyer told the jury at the U.S. Court for the Eastern District of Arkansas that consuming Prempro caused the growth of a breast tumor, for which she had to undergo a mastectomy.

Prempro is a combination of the hormones estrogen and progesterone to overcome the effects of menopause and has been sold in the United States since 1995.

Wyeth’s lawyers argued that the drug company had met its ethical and legal obligations in determining the treatment's safety, before U.S. District Judge William R. Wilson, Jr.

Reeves’ lawyers have said that she is seeking an unspecified judgment that could exceed $1 million.


NL
'"/>




Page: 1

Related medicine news :

1. Wyeth Launches Vaccine for Pneumococcal Disease in India
2. Wyeth Pharma Wins Law Suit
3. Verdict Against Wyeth Pharma in Prempro Case
4. Simmering Curry - Murg Masala Embroiled In a Thick Soup
5. Medical Education in Australia Embroiled in Scandals
6. AAI Pharma Files Lawsuit Against Dr. Reddys Laboratories
7. Lawsuit Against Sunscreen Makers For False Claims of Protection Against Skin Cancer
8. Lawsuit against Google
9. KFC Targeted in Lawsuit
10. American Wins Lawsuit Over Penile Implant Malfunction
11. Soft Drink Companies Settle Lawsuit
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/16/2017)... ... ... Maury Regional Health has announced a large-scale adoption of AccuVein vein visualization ... Regional Medical Center is making vein visualization part of their standard of care. , ... importantly, helps our staff members locate a vein that will provide good access to ...
(Date:8/16/2017)... ... August 16, 2017 , ... A global leader in the treatment ... clinics in all 29 Indian states—bringing the country one step closer to eliminating clubfoot ... the nonprofit organization is on track to enroll 10,000 children in the clubfoot treatment ...
(Date:8/16/2017)... ... , ... Fusion Flix Inc., a Telly Award Winning, Non Profit Corporation has ... viewers in a partnership with the Amazon Video Direct Streaming Distribution Platform. , Their ... Ray disc in 2018. Proceeds will be going to further health research. , ...
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... TopConsumerReviews.com recently ... Lab Testing . , The healthcare industry in the United States has undergone ... are the days of needing to have a doctor’s order to get a blood ...
(Date:8/16/2017)... , ... August 16, 2017 , ... First Choice ... States, named Dr. Douglas J. Harrison, as the new Medical Director of its Sienna ... new facility Medical Director of our Sienna Plantation location,” said Dr. Michael (Derek) Caraway, ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... , Aug. 15, 2017  AOTI Inc. announced today that its ... Inc., has recently opened a New York City Office in ... of its unique Topical Wound Oxygen (TWO 2 ) homecare therapy. ... Accreditation Commission for Health Care (ACHC) under the company,s DMEPOS accreditation ... ...
(Date:8/8/2017)... Israel, Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), ... today reports its financial results for the second quarter ... during the second quarter 2017 and to date: ... clinical development programs for the Company,s lead project, BL-8040: ... pivotal study with BL-8040 as novel stem cell mobilization ...
(Date:8/7/2017)... Mich. , Aug. 7, 2017 Diplomat Pharmacy, ... of Joel Saban as president, effective Aug. 7, ... Urick has decided to pursue other interests and will ... "During his tenure, Paul has served us in multiple leadership ... Specialty Pharmacy in Jun. 2015 and has provided decisive, strategic ...
Breaking Medicine Technology: